Medical News

RSS

Many women not screened for gonorrhea and chlamydia infection during pregnancy

Many women are not screened for chlamydia and gonorrhea infection during their pregnancy, and follow-up testing is not always performed as medically recommended for those who test positive for chlamydia, according to a study published online in the American Journal of Obstetrics and Gynecology.

From Quest Diagnostics 24 May 2012

Severity of nocturnal hypoxemia and SDB independently predict both T2DM and HbA1c levels

The severity of sleep disordered breathing and nocturnal hypoxemia independently predict both glycosylated hemoglobin (HbA1c) levels and type 2 diabetes mellitus (T2DM), according to a new study.

24 May 2012

Study confirms links between metabolic dysregulation, SDB and obesity

Weight loss improved both metabolic parameters and sleep-disordered breathing (SDB) in obese children in a new study from researchers in Belgium, confirming links between metabolic dysregulation, SDB and obesity.

24 May 2012

Health Canada accepts Seattle Genetics’ ADCETRIS NDS for review

Seattle Genetics, Inc. announced today that the validation period is complete and Health Canada has accepted for review its New Drug Submission (NDS) for the use of ADCETRIS (brentuximab vedotin) in relapsed Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma.

24 May 2012

Acne pills can cause eye infections

Millions of teenagers suffer from acne, and they deal with the embarrassing skin blemishes by taking popular prescription medications such as Accutane or Roaccutane. Now, however, research from Tel Aviv University shows that these pills can also cause eye infections such as conjunctivitis (pink eye) or sties.

24 May 2012

Children of mothers with low vitamin D status in pregnancy more likely to have body fat

Children are more likely to have more body fat during childhood if their mother has low levels of Vitamin D during pregnancy, according to scientists at the Medical Research Council Lifecourse Epidemiology Unit (MRC LEU), University of Southampton.

24 May 2012

U.N. SG Ban praises commission on life-saving commodities, says more effort needed to improve maternal, child mortality rates

At the opening of the U.N. Commission on Life-Saving Commodities for Women and Children on Tuesday, U.N. Secretary-General Ban Ki-moon praised the commission but "said that much remains to be done to save the lives of the 800 women and more than 20,000 children who die every day from preventable causes," the U.N. News Centre reports.

24 May 2012

Bayer submits regorafenib NDA with FDA for treatment of mCRC

Bayer HealthCare announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the oral multi-kinase inhibitor regorafenib for the treatment of patients with metastatic colorectal cancer.

24 May 2012

LabCorp, XDx partner to develop and commercialize SLE flare predictor test

XDx, Inc. announced today that it has entered into a collaboration and license agreement with Laboratory Corporation of America Holdings (LabCorp)whereby each party will collaborate in marker discovery, and LabCorp will develop and commercialize a diagnostic test to predict flares of systemic lupus erythematosus.

24 May 2012

Study: Phthalates from PVC flooring materials is taken up by our bodies

A new study at Karlstad University in Sweden shows that phthalates from PVC flooring materials is taken up by our bodies. Phthalates are substances suspected to cause asthma and allergies, as well as other chronic diseases in children. The study shows that children can ingest these softening agents with food but also by breathing and through the skin.

24 May 2012

Zytoprotec completes PD-protec Phase I/II trial on kidney failure

Zytoprotec, a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec.

24 May 2012

USPTO issues patent to QRxPharma’s MoxDuo for treatment of acute and chronic pain

QRxPharma Limited announced today that the United States Patent and Trademark Office (USPTO) issued the Company U.S. Patent No. 8,182,837, which does not expire until 2023.

24 May 2012

Omron introduces new wireless sleep monitoring device

ResMed Inc. today announced the launch of the first product in Japan using technology from its recently acquired company, BiancaMed. The product, launched by BiancaMed partner Omron Healthcare, is a new wireless sleep monitoring device.

From ResMed Corp 24 May 2012

EMA accepts MAA filing of Takeda’s alogliptin for type 2 diabetes

Furiex Pharmaceuticals, Inc. today confirmed that Takeda Global Research & Development Centre (Europe) Ltd. received confirmation on the acceptance of the submission of a Marketing Authorization Application, or MAA, from the European Medicines Agency for alogliptin, a selective dipeptidyl peptidase IV, or DPP-4, inhibitor for the treatment of type 2 diabetes.

24 May 2012

FMCNA announces new educational resources to enhance RightStart

Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, announced today new educational resources to enhance RightStart™, its innovative program designed to educate and empower new dialysis patients.

24 May 2012

Viewpoints: The promise and perils of prostate screening; Presidential candidates shy away from frank discussion of spending

After an exhaustive process, the U.S. Preventive Services Task Force has announced its final recommendation on PSA-based prostate cancer screening. It finds that the known harms of screening outweigh the potential benefits for men who have no cancer symptoms. It notes that all screening studies have demonstrated considerable harms associated with screening, but only one major study found evidence that screening saves lives -- and that study has some internal inconsistencies.

24 May 2012

Phase I/II clinical trial of novel dialysate completed by Zytoprotec

Zytoprotec, a company developing drugs based on active cytoprotection, today announced the completion of a Phase I/II clinical trial with its lead product, PD-protec™. The product is developed to improve the treatment of patients with kidney failure.

23 May 2012

New liquid urine control available from Randox

The new Randox Acusera liquid urine control is designed to be both easy and convenient for laboratory staff to use. The inclusion of fully assayed target values for 18 commonly performed urine chemistry tests including Microalbumin and hCG enables consolidation and ultimately cost savings.

From Randox Laboratories Ltd. 23 May 2012

Alteplase can benefit stroke patients aged over 80 years according to new studies

The Lancet today publishes two papers Online First about the use of alteplase in stroke, timed to coincide with their presentation at the European Stroke Conference in Lisbon, Portugal.

23 May 2012

MTI develops SureTouch Wireless system for breast cancer screening

Medical Tactile, Inc. (MTI), with the support of The Pre-Mammogram Foundation and Qualcomm Incorporated, today announced that they have developed a pre-commercial SureTouch Wireless system that uses 3G-enabled tactile sensor technology for breast cancer screening.

23 May 2012